We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$192M
AUM Growth
+$3.31M
Cap. Flow
+$10.5M
Cap. Flow %
5.46%
Top 10 Hldgs %
24.46%
Holding
454
New
344
Increased
40
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2M
2
GS icon
Goldman Sachs
GS
+$1.47M
3
GSK icon
GSK
GSK
+$1.35M
4
JNJ icon
Johnson & Johnson
JNJ
+$608K
5
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$360K

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$3.92M
2
BF.B icon
Brown-Forman Class B
BF.B
+$2.98M
3
WBA
Walgreens Boots Alliance
WBA
+$1.52M
4
GIS icon
General Mills
GIS
+$227K
5
YUM icon
Yum! Brands
YUM
+$225K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.13%
2 Healthcare 17.42%
3 Financials 15.91%
4 Communication Services 8.72%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCE icon
51
BCE
BCE
$20.2B
$1.64M 0.85%
37,996
-525
-1% -$23.6K
AIG icon
52
American International
AIG
$41.7B
$1.56M 0.81%
28,680
-195
-0.7% -$11.5K
KO icon
53
Coca-Cola
KO
$377B
$1.54M 0.8%
35,380
+44
+0.1% +$1.98K
SO icon
54
Southern Company
SO
$109B
$1.52M 0.8%
34,151
+2,150
+7% +$95.4K
BP icon
55
BP
BP
$116B
$1.46M 0.76%
38,647
+2,640
+7% +$99.5K
VOD icon
56
Vodafone
VOD
$36.3B
$1.44M 0.75%
51,890
+6,690
+15% +$199K
GS icon
57
Goldman Sachs
GS
$300B
$1.43M 0.74%
+5,660
New +$1.47M
NVO
58
Novo Nordisk
NVO
$208B
$1.35M 0.71%
54,898
-500
-0.9% -$13.1K
WFC.PRL icon
59
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.71B
$1.34M 0.7%
1,040
– –
PFE icon
60
Pfizer
PFE
$143B
$1.16M 0.6%
34,310
– –
COP icon
61
ConocoPhillips
COP
$147B
$1.09M 0.57%
18,374
-698
-4% -$39.5K
BSV icon
62
Vanguard Short-Term Bond ETF
BSV
$44.7B
$908K 0.47%
11,573
– –
EEFT icon
63
Euronet Worldwide
EEFT
$2.72B
$859K 0.45%
10,885
+475
+5% +$41.8K
HD icon
64
Home Depot
HD
$331B
$849K 0.44%
4,765
-626
-12% -$117K
USB icon
65
US Bancorp
USB
$98.2B
$757K 0.4%
14,984
-2,057
-12% -$113K
OAK
66
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$710K 0.37%
17,925
-3,700
-17% -$159K
BNS icon
67
Scotiabank
BNS
$107B
$691K 0.36%
11,200
-250
-2% -$15.9K
LYB icon
68
LyondellBasell Industries
LYB
$20B
$684K 0.36%
6,475
-400
-6% -$44.7K
SCZ icon
69
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$674K 0.35%
10,342
– –
INTC icon
70
Intel
INTC
$455B
$657K 0.34%
12,613
+841
+7% +$40K
APD icon
71
Air Products & Chemicals
APD
$65.7B
$600K 0.31%
3,775
-450
-11% -$74.2K
ARCC icon
72
Ares Capital
ARCC
$13.5B
$590K 0.31%
37,150
– –
IRM icon
73
Iron Mountain
IRM
$36.4B
$534K 0.28%
16,250
+8,950
+123% +$302K
KDP icon
74
Keurig Dr Pepper
KDP
$42.3B
$474K 0.25%
4,000
– –
FPI
75
Farmland Partners
FPI
$408M
$470K 0.25%
56,267
-7,490
-12% -$60.8K
1 2
3
4 5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Kavar Capital Partners Group's Q1 2018 Portfolio in Review

As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.

  • Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
  • Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
  • Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
  • Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
  • Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
  • Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
  • Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.